General Notices

• Notice of Informational Webinar on PAR-23-145, Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
  (NOT-GM-23-044)
  National Institute of General Medical Sciences
  

• Notice of Information Regarding Close-Out and Transition Planning for the Newborn Screening Translational Research Network
  (NOT-HD-23-012)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

Notice of Changes to Funding Opportunities

• Notice of Change to RFA-AG-24-002, "Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)"
  (NOT-AG-23-030)
  National Institute on Aging
  

• Notice of Clarification for Inclusion of Wellness-Oriented Programming and Activities for PA-21-151 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  (NOT-AT-24-008)
  National Center for Complementary and Integrative Health
  

• Notice of Change to the Letters of Intent Due Date for "RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)"
  (NOT-DK-23-029)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change to RFA-HD-24-005 "Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)"
  (NOT-HD-23-017)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Extension of the Due Date of PAR-23-161: "Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)"
  (NOT-TR-23-021)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
  (NOT-NS-23-070)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R34 Clinical Trial Not Allowed)
  (NOT-NS-23-071)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
  (NOT-NS-23-087)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Human Virome Project: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)
  (NOT-RM-23-014)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed)
  (NOT-RM-23-015)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Project (HVP) (U24 Clinical Trial Not Allowed)
  (NOT-RM-23-016)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterize the Human Virome in Longitudinal, Diverse Cohorts Across the Lifespan (U54 Clinical Trial Not Allowed)
  (NOT-RM-23-017)
  Office of Strategic Coordination (Common Fund)
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
  (NOT-CA-23-070)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups
  (NOT-HL-23-089)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
  (NOT-MH-23-275)
  National Institute of Mental Health
  

• Notice of Special Interest: Notice of Availability of Administrative Supplements for the NCATS Clinical and Translational Science Award (CTSA) Program
  (NOT-TR-23-020)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
  (PAR-23-199)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Cancer Institute
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 25, 2025
  
  

• Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed)
  (PAR-23-203)
  National Institute of Allergy and Infectious Diseases
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Application Receipt Date(s): September 01, 2023
  
  

• Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
  (PAR-23-214)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): October 04, 2023
  
  

• Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional)
  (RFA-AG-24-025)
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): November 03, 2023
  
  

• Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)
  (RFA-AG-24-026)
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): November 03, 2023
  
  

• HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
  (RFA-AT-24-003)
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): October 02, 2023
  
  

• Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
  (RFA-DK-23-008)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 18, 2023
  
  

• Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
  (RFA-HG-23-017)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
  (RFA-HG-23-018)
  National Human Genome Research Institute
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.